標(biāo)題: Titlebook: Cancer Chemoprevention; Volume 2: Strategies Gary J. Kelloff,Ernest T. Hawk,Caroline C. Sigman Book 2005 Humana Press 2005 carcinoma.endosc [打印本頁(yè)] 作者: controllers 時(shí)間: 2025-3-21 19:24
書(shū)目名稱Cancer Chemoprevention影響因子(影響力)
作者: INERT 時(shí)間: 2025-3-21 22:01 作者: SOBER 時(shí)間: 2025-3-22 01:05 作者: 該得 時(shí)間: 2025-3-22 08:20
Management of Neurogenic Overactive Bladdera, Wilms tumor, osteosarcoma, testicular cancer, Hodgkin’s disease, diffuse large B cell lymphoma, and other neoplasms. Mortality for breast cancer has been reduced as a result of improvements in chemoprevention, early detection, and therapy. For many other solid tumors, however, progress has been more limited.作者: 巨碩 時(shí)間: 2025-3-22 12:36
Evaluation of Spasticity in Adultsrts from epidemiologic observational studies, preclinical studies, and biomarker-based trials, the number of Phase III (randomized, placebo-controlled) trials has remained relatively small because of the large number of subjects required, the long duration of study, and the high cost of these studies.作者: 無(wú)王時(shí)期, 時(shí)間: 2025-3-22 16:17
https://doi.org/10.1007/978-1-59259-768-0carcinoma; endoscopy; imaging; morbidity; positron emission tomography作者: 無(wú)王時(shí)期, 時(shí)間: 2025-3-22 17:16 作者: bile648 時(shí)間: 2025-3-22 23:12 作者: Vaginismus 時(shí)間: 2025-3-23 02:05
M. Sindou M.D., D.Sc. Biol.,M. F. Milletancer were estimated to be diagnosed in the United States (US), and about 555,500 persons were expected to die of cancer, i.e., more than 1500 every day (.). Despite small decreases in overall cancer incidence and mortality rates in the US since the early 1990s, the total number of recorded cancer d作者: 經(jīng)典 時(shí)間: 2025-3-23 09:32 作者: GLUE 時(shí)間: 2025-3-23 12:06 作者: Choreography 時(shí)間: 2025-3-23 14:07 作者: Simulate 時(shí)間: 2025-3-23 18:26
Neuroanatomical bases of spasticitymor development. However, many of the morphologic and molecular abnormalities found in malignant tumors also exist in precursor or incipient lesions. New laboratory techniques, such as microdissection and polymerase chain reaction (PCR), have stimulated interest in early cancer development and event作者: GRE 時(shí)間: 2025-3-23 23:03
Spinal cord stimulation for spasticitye, as well as in disease-related processes such as cancer, where they are manifested in response to numerous alterations in gene expression (.). Therefore, the accurate and reproducible measurement of nuclear structure changes can provide important objective information when assessing and managing t作者: 蜿蜒而流 時(shí)間: 2025-3-24 03:06 作者: 帶傷害 時(shí)間: 2025-3-24 07:14
Assessment of Spasticity in Adults a few immunohistochemical markers in tumors have guided treatment of most cancers. By studying gene expression patterns for a large number of genes, morphologically similar tumors can be further subdivided into distinct categories of clinical relevance. Recent studies have applied DNA microarrays t作者: effrontery 時(shí)間: 2025-3-24 11:28 作者: 淘氣 時(shí)間: 2025-3-24 16:24
Management of Neurogenic Overactive Bladdera, Wilms tumor, osteosarcoma, testicular cancer, Hodgkin’s disease, diffuse large B cell lymphoma, and other neoplasms. Mortality for breast cancer has been reduced as a result of improvements in chemoprevention, early detection, and therapy. For many other solid tumors, however, progress has been m作者: outset 時(shí)間: 2025-3-24 19:36 作者: Sputum 時(shí)間: 2025-3-25 01:45
Evaluation of Spasticity in Adultsility is both inherited and acquired. Genes that affect cancer susceptibility can be found in those controlling behavior, carcinogen metabolism, and cellular response to carcinogen exposure. Genetic traits affect DNA repair, cell cycle control, and immune response. Polymorphic genetic variants are u作者: 小隔間 時(shí)間: 2025-3-25 04:59 作者: 骨 時(shí)間: 2025-3-25 09:18
Evaluation of Spasticity in Adultsd sufficient expenditure of resources. Ruffin and Baron (.) point out that less than 10% of subjects identified as eligible for the trials are ultimately recruited. Since prevention trial subjects are well, they may feel that they have little to gain by participating. Concerns over waiting, travel t作者: SCORE 時(shí)間: 2025-3-25 11:53 作者: 很像弓] 時(shí)間: 2025-3-25 19:44 作者: LVAD360 時(shí)間: 2025-3-25 21:34 作者: 發(fā)電機(jī) 時(shí)間: 2025-3-26 02:17 作者: Introvert 時(shí)間: 2025-3-26 05:54
Pathology of Incipient Neoplasiamor development. However, many of the morphologic and molecular abnormalities found in malignant tumors also exist in precursor or incipient lesions. New laboratory techniques, such as microdissection and polymerase chain reaction (PCR), have stimulated interest in early cancer development and events that precede invasion.作者: 離開(kāi)真充足 時(shí)間: 2025-3-26 12:16 作者: Accolade 時(shí)間: 2025-3-26 12:45 作者: 根除 時(shí)間: 2025-3-26 20:05
Preclinical Animal Models for the Development of Cancer Chemoprevention Drugsays afford a strategic framework for evaluating agents according to defined criteria, and not only provide evidence of agent efficacy, but also serve to generate valuable dose-response, toxicity, and pharmacokinetic data required prior to Phase I clinical safety testing. Based on preclinical efficac作者: promote 時(shí)間: 2025-3-27 00:17 作者: 蒸發(fā) 時(shí)間: 2025-3-27 01:20
Genetic Polymorphisms and Risk Assessment for Cancer Chemoprevention shorter duration. This chapter describes concepts underlying genetic susceptibility and current technology used to assess it, provides specific examples of low-penetrance genes involved in cancer susceptibility, and comments on the implications for cancer prevention.作者: 情節(jié)劇 時(shí)間: 2025-3-27 06:03 作者: 動(dòng)作謎 時(shí)間: 2025-3-27 10:03 作者: Choreography 時(shí)間: 2025-3-27 13:46
Book 2005understanding of carcinogenesis and cancer invasive life-threatening disease, and those whose mo- progression. This knowledge is moving the focus of cancer lation can “reasonably predict” clinical benefit and, therapeutics, including cancer preventive treatments, to therefore, serve as surrogate end作者: 安慰 時(shí)間: 2025-3-27 18:51 作者: mettlesome 時(shí)間: 2025-3-27 23:30
Spinal cord stimulation for spasticity, gene families (HMGA, SWI/SNF modifiers, RARs, MARs, etc.), and key structural and regulatory proteins (e.g., nuclear matrix proteins, HMG proteins, nuclear histones H1, H2A, H2B, H3, and H4, and SWI/SNF complex) have been identified as being important to maintenance of nuclear chromatin structure 作者: cyanosis 時(shí)間: 2025-3-28 04:54
Evaluation of Spasticity in Adults shorter duration. This chapter describes concepts underlying genetic susceptibility and current technology used to assess it, provides specific examples of low-penetrance genes involved in cancer susceptibility, and comments on the implications for cancer prevention.作者: 雜役 時(shí)間: 2025-3-28 07:39 作者: Congruous 時(shí)間: 2025-3-28 10:36 作者: Substitution 時(shí)間: 2025-3-28 16:14 作者: 谷類 時(shí)間: 2025-3-28 21:43 作者: 咆哮 時(shí)間: 2025-3-29 00:04
Preclinical Animal Models for the Development of Cancer Chemoprevention Drugss with the aim of preventing human cancer. If little is known about a potential agent, the first step is a sequential series of short-term in vitro prescreens of mechanistic, biochemical assays. These assays provide quantitative data to help establish an early indication of chemopreventive efficacy 作者: Antigen 時(shí)間: 2025-3-29 05:23 作者: forager 時(shí)間: 2025-3-29 10:07
Modeling Human Colorectal Cancer in Mice for Chemoprevention Studieshas focused on human cancer cell lines and xenografts of human cancer cells in immunologically compromised mice. Though these experimental approaches have provided much information on cancer cells, they have precluded any insight into the intricate cross-talk between transformed cells and the host i作者: 良心 時(shí)間: 2025-3-29 13:32
Pathology of Incipient Neoplasiamor development. However, many of the morphologic and molecular abnormalities found in malignant tumors also exist in precursor or incipient lesions. New laboratory techniques, such as microdissection and polymerase chain reaction (PCR), have stimulated interest in early cancer development and event作者: reperfusion 時(shí)間: 2025-3-29 18:21 作者: inflame 時(shí)間: 2025-3-29 20:03
Enabling Discovery Through Online Cancer Genome Databases and Analytic Toolsic events associated with cancer are quite diverse, with much genetic heterogeneity within and among tumors, careful analysis of the complex data has revealed a limited number of common categories of acquired capabilities of cancers (.). As described by Hanahan and Weinberg, these capabilities inclu作者: 聯(lián)想記憶 時(shí)間: 2025-3-30 00:04
Functional Genomics for Identifying Surrogate Endpoint Biomarkers in Breast Cancer Chemoprevention a few immunohistochemical markers in tumors have guided treatment of most cancers. By studying gene expression patterns for a large number of genes, morphologically similar tumors can be further subdivided into distinct categories of clinical relevance. Recent studies have applied DNA microarrays t作者: 贊美者 時(shí)間: 2025-3-30 05:47
Clinical Applications of Proteomicsns and their possible post-translational modifications. However, the effort made to elucidate this index is not likely to be rewarded by any real clinical impact, as the function of proteins is closely tied to their cellular, tissue, and physiological context. The ultimate goal of clinical proteomic作者: expository 時(shí)間: 2025-3-30 10:33
Bioinformatics and Whole-Genome Technologiesa, Wilms tumor, osteosarcoma, testicular cancer, Hodgkin’s disease, diffuse large B cell lymphoma, and other neoplasms. Mortality for breast cancer has been reduced as a result of improvements in chemoprevention, early detection, and therapy. For many other solid tumors, however, progress has been m作者: 邪惡的你 時(shí)間: 2025-3-30 13:44 作者: CAGE 時(shí)間: 2025-3-30 16:36 作者: 咆哮 時(shí)間: 2025-3-31 00:17
Design Issues in Prostate Cancer Chemoprevention Trialsrts from epidemiologic observational studies, preclinical studies, and biomarker-based trials, the number of Phase III (randomized, placebo-controlled) trials has remained relatively small because of the large number of subjects required, the long duration of study, and the high cost of these studie作者: Cpr951 時(shí)間: 2025-3-31 02:42 作者: Ingratiate 時(shí)間: 2025-3-31 05:13
Prostate Cancer PreventionS) men, who have a 1 in 6 lifetime risk of a prostate cancer diagnosis and a 1 in 30 lifetime risk of prostate cancer death (.). Over the past decade, increased use of serum prostate-specific antigen (PSA) testing for prostate cancer screening has increased the fraction of men diagnosed with localiz作者: Contend 時(shí)間: 2025-3-31 12:52
Use of PSA to Evaluate Risk and Progression of Prostate Cancern involves inhibiting carcinogenesis through application of noncytotoxic nutrients and pharmacologic compounds, thereby preventing the development and progression of malignant cells. Prostate cancer is one of the primary targets for chemopreventive studies. It has a long latency period, and autopsy 作者: neurologist 時(shí)間: 2025-3-31 15:23 作者: 變化無(wú)常 時(shí)間: 2025-3-31 19:13
2196-9906 rly detection, overall cancer incidence has increased, pharmacodynamic markers), and markers that measure cancer-associated morbidity is considerable, and overall prognosis as well as predict responses to specific therapy. cancer survival has remained relatively flat over the past All these biomarke作者: 種族被根除 時(shí)間: 2025-3-31 21:51
Botulinum Toxin Injections for Spasticityage of 14, who has had no breast biopsies, and whose mother had breast cancer, will develop breast cancer by the age of 70 can be calculated as 0.116, or 11.6%, using the Gail model for breast cancer risk (.). In this paper, breast cancer will usually be the disease of interest, but the ideas apply to any disease.作者: 不可救藥 時(shí)間: 2025-4-1 04:23
Gamma Knife radiosurgery for cerebral AVMs,estrogen receptor (ER)-positive (.). If a proportion of those tumors could be prevented, morbidity resulting from surgery, radiation, and chemotherapy, as well as breast cancer-related mortality, could be reduced.
